Search

Your selection

Clear all

Filter by content type

Filter by content year

News

Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

May 27, 2025 - … with our government partners." The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … with our government partners." The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … with our government partners." The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
News

Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study

September 25, 2019 - … announced positive topline results from the randomized, double-blind, placebo-controlled Phase 1b safety, … announced positive topline results from the randomized, double-blind, placebo-controlled Phase 1b safety, … announced positive topline results from the randomized, double-blind, placebo-controlled Phase 1b safety, …
News

Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

November 2, 2023 - … Clinical Trial The Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging … Clinical Trial The Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging … Clinical Trial The Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging …
News

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

December 2, 2024 - … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … at least 25% over the age of 65. The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
News

Vaxart Reports Topline Results from Phase 2 Trial of Teslexivir™ for the Treatment of Condyloma

June 4, 2018 - … the Teslexivir Trial This teslexivir trial was a Phase 2 double-blind, randomized, placebo-controlled trial designed … the Teslexivir Trial This teslexivir trial was a Phase 2 double-blind, randomized, placebo-controlled trial designed … the Teslexivir Trial This teslexivir trial was a Phase 2 double-blind, randomized, placebo-controlled trial designed …
News

Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

September 30, 2024 - … mRNA vaccine for this virus.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … mRNA vaccine for this virus.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … mRNA vaccine for this virus.” The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
News

Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

December 21, 2023 - … Clinical Trial The Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging … Clinical Trial The Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging … Clinical Trial The Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging …
News

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers

April 30, 2024 - … Clinical Trial This Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging … Clinical Trial This Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging … Clinical Trial This Phase 1, multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging …
News

Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset

July 7, 2021 - … as tiered royalties ranging from the low-single to low-double digits on product sales for multiple indications. … as tiered royalties ranging from the low-single to low-double digits on product sales for multiple indications. … as tiered royalties ranging from the low-single to low-double digits on product sales for multiple indications. …
News

Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

June 13, 2024 - … About the COVID-19 Phase 2b Trial The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … About the COVID-19 Phase 2b Trial The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled … About the COVID-19 Phase 2b Trial The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled …
Scroll to Top